BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Prognosis
7 results:

  • 1. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Src Family Kinases in Hepatocellular Carcinoma.
    Yao D; Deng Y; Zhang S; Liang L; Zhang L; Weng S; Chen S
    Front Biosci (Landmark Ed); 2023 May; 28(5):90. PubMed ID: 37258470
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
    Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
    Hou Y; Zhang G
    Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
    Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A new clinical prognostic nomogram for liver cancer based on immune score.
    Shen Q; Hu G; Wu J; Lv L
    PLoS One; 2020; 15(7):e0236622. PubMed ID: 32730361
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
    Dong F; Yang Q; Wu Z; Hu X; Shi D; Feng M; Li J; Zhu L; Jiang S; Bao Z
    Biomed Pharmacother; 2019 Jun; 114():108856. PubMed ID: 30981109
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
    Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
    J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.